Lighthouse Announces $370 Million Series C Investment Led by KKR to Accelerate Platform Innovation and Growth
Lighthouse, the leading commercial intelligence platform for the travel & hospitality industry, today announced an approximately $370 million growth investment led by global investment firm, KKR. This investment accelerates Lighthouse's mission to reimagine commercial strategy for the $15 billion travel & hospitality technology market. Proceeds from the investment will be used to drive continued product innovation across Lighthouse's platform, strategic acquisitions, and global expansion efforts.
Lighthouse’s suite of products provides revenue managers, commercial leaders, and accommodation owners with easy-to-use tools that drive incremental bookings, streamline operations, and enable a better customer experience for guests. The platform is underpinned by proprietary technology that processes over 400 terabytes of travel and market data daily and leverages AI to deliver real-time insights that enable customers to make better and more efficient operational decisions. Lighthouse has established itself as hospitality's leading commercial intelligence platform, with 700+ employees worldwide and an industry-leading NPS score of 70+.
“We're extremely grateful to the 70,000+ hospitality providers, who have placed their trust in Lighthouse,” said Sean Fitzpatrick, CEO of Lighthouse. “I couldn’t be more energized by what we’re working towards. We’re just getting started in making hospitality data and tools more powerful, accessible, and affordable. This investment by KKR significantly accelerates our ability to enhance our commercial platform through expanded AI capabilities and additional data sets, enabling us to better serve our existing customers while continuing to expand across the hospitality market.”
KKR has established a proven track record of supporting technology-focused growth companies, having invested approximately $23 billion in related investments since 2010 through its private equity and growth equity funds and built a dedicated global team of nearly 70 investment professionals with deep technology growth equity expertise. Lighthouse will be able to leverage KKR’s extensive industry experience, local resources and global network to help further enhance its customer offerings and tap into new segments globally.
“Lighthouse has demonstrated an exceptional ability to support hoteliers of all sizes – ranging from global chains to independent properties – by addressing the unique needs of each segment,” said Stephen Shanley, Partner and Head of Tech Growth in Europe at KKR. “Their strong track record, customer loyalty, and proven ability to deliver value across varied markets position them as the leading platform in this space. We are proud to support Lighthouse in expanding its global footprint, driving continued innovation, and enhancing its market leading offerings.”
This latest funding builds on Lighthouse’s $80M Series B investment round, which was completed in November 2021. Existing investors Spectrum Equity, F-Prime Capital, Eight Roads Ventures, and Highgate Technology Ventures will continue their participation in the business.
KKR is making the investment in Lighthouse through its Next Generation Technology III Fund.
William Blair acted as financial advisor. Latham & Watkins served as legal advisor to Lighthouse and Gibson Dunn as legal advisor to KKR.
About Lighthouse
Lighthouse (formerly OTA Insight) is the leading commercial platform for the travel & hospitality industry. We transform complexity into confidence by providing actionable market insights, business intelligence, and pricing tools that maximize revenue growth. We continually innovate to deliver the best platform for hospitality professionals to price more effectively, measure performance more efficiently, and understand the market in new ways. Trusted by over 70,000 hotels in 185 countries, Lighthouse is the only solution that provides real-time hotel and short-term rental data in a single platform. We strive to deliver the best possible experience with unmatched customer service. We consider our clients as true partners—their success is our success. For more information about Lighthouse, please visit: https://www.mylighthouse.com.
About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241120724034/en/
Contacts
Lighthouse
Adam Swart
pr@mylighthouse.com
KKR
FGS Global
Alastair Elwen / Jack Shelley
+44 20 7251 3801
KKR-LON@fgsglobal.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CARB-X Awards Additional Funding to Debiopharm for Continued Development of Early-Stage Antibiotic Targeting Drug-Resistant N. Gonorrhoeae Infections21.11.2024 14:00:00 CET | Press Release
Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, is proud to announce the extension of funding from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global non-profit partnership dedicated to supporting early-stage antibacterial research and development to address the rising threat of drug-resistant bacteria. This funding will support the preclinical development of Debio 1453, a novel antibiotic specifically designed to combatNeisseria gonorrhoeaeinfections. In line with the Debiopharm’s vision to set a new standard for treating N. gonorrhoeae infections by developing antibiotics with targeted activity, while potentially avoiding microbiome dysbiosis, the newly awarded $5.76 million USD will facilitate the advancement of essential preclinical research, positioning Debio 1453 for clinical progression. With Debio 1453, Debiopharm aims to provide a potentially valuable addition to the current antibiotic armamentarium, as
PwC Opens Google Cloud AI Experience Zones to Feature Solutions Powered by Google Cloud’s Generative AI21.11.2024 14:00:00 CET | Press Release
PwC today announced the opening of its first Google Cloud AI Experience Zone at the firm’s US Acceleration Center in Bengaluru, India. It also announced additional, near-term planned openings of Google Cloud AI Experience Zones in Boston, MA and San Francisco, CA. At each, PwC will invite clients to get hands-on experience with existing, next-gen solutions, powered by Google Cloud’s AI technology, including Google Gemini models, Vertex AI and more. “We're thrilled to deepen our alliance with Google Cloud and harness its groundbreaking AI capabilities in this innovative space,” said Jason Ruge, Partner, US Google Cloud Alliance Leader, PwC US. “These Google Cloud AI Experience Zones will help showcase how PwC’s industry-specific solutions built on Google Cloud technology, including Vertex AI and Gemini, can revolutionize digital and business transformations for our customers.” PwC’s leading industry capabilities enable business model reinvention and help companies transform their busine
United States, China, and United Kingdom Lead the Global AI Ranking According to Stanford HAI’s Global AI Vibrancy Tool21.11.2024 14:00:00 CET | Press Release
The Stanford Institute for Human-Centered AI (HAI) AI Index today released its Global AI Vibrancy Tool which allows flexible comparisons of 36 countries based on 42 openly available AI-specific indicators. Comparisons between countries can be made using either absolute or per capita versions of the indicators and are supported by interactive visualizations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241121006002/en/ Graphic: Stanford Institute for Human-Centered Artificial Intelligence (HAI) The Global AI Vibrancy Tool measures the strength of the AI ecosystems based on 8 pillars — research and development, responsible AI, economy, education, diversity, policy and governance, public opinion, and infrastructure — with indicators including AI journal publications, total AI private investment, AI legislation passed, and foundation model datasets. It is designed to empower policymakers, industry leaders, researchers, and the
Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity21.11.2024 14:00:00 CET | Press Release
Altasciences is proud to have supported Metsera, Inc., a clinical stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, on its nonclinical and early-stage clinical trials. This support includes a recent Phase I/II trial of MET-097i, an ultra-long-acting injectable amylin analog, fully biased GLP-1 receptor agonist. In September, Metsera reported positive topline results from the clinical trial conducted at Altasciences’ facility, in which MET-097i demonstrated a 7.5% reduction in body weight from baseline at day 36 (one week after the final dose) and a 380-hour half-life. This work enabled Metsera to recently initiate a randomized 16-week Phase II trial of MET-097i. In addition to clinical conduct, Altasciences supported Metsera with its Proactive Drug Development solution, including nonclinical, bioanalysis, CRO and program management services for several additional therapeutic candidates. Over the past six months, Altascienc
From AI to Energy Optimization: Barilla and Plug and Play Recognize the Most Innovative Food-Tech Startups21.11.2024 14:00:00 CET | Press Release
Barilla and Plug and Play, the world's largest open innovation platform, have announced the four winning projects of Good Food Makers, a program launched in 2019 with the goal of stimulating the development of new sustainable food solutions. The winners will participate in an eight-week program, working closely with Barilla managers to develop and test new technologies, benefiting from the vision of a company that has been dedicated to producing good and high-quality food for 147 years. The winners of the four categories in the 2024 edition—AI for Consumer Insights, Tasty and Healthy, Energy Shift, and Smart Start: Operators Onboarding—are: Voxpopme: A UK-based startup that is revolutionizing qualitative feedback analysis using artificial intelligence. The platform enables quick and in-depth understanding of consumer opinions, analyzing video and text data to highlight specific customer needs. This helps businesses create products that align more closely with market expectations and es
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom